Track market-moving stories before they get noisy

Key Takeaways DuPont launches AmberChrom SIL silica gel to enhance peptide purification, including GLP-1 therapeutics.Available in C8 and C18 chemistries, the new media offers high resolution, stability and scalability.DuPont's new media integrates with existing chromatography resins to optimize purity, yield and recovery.
DuPont de Nemours, Inc. (DD - Free Report) has launched AmberChrom SIL silica gel, a new reverse-phase silica-based chromatography media designed to support the purification and manufacturing of peptide therapeutics, including glucagon-like peptide-1 (GLP-1) receptor agonists. The launch expands DuPont’s bioprocessing purification portfolio and strengthens its suitability for high-purity polishing.

Growing demand for peptide therapeutics for the treatment of diabetes, obesity and other chronic conditions is increasing the need for efficient purification technologies at a larger scale. AmberChrom SIL silica gel is designed to help biopharmaceutical manufacturers meet stringent purity requirements while maintaining high yields.

Available in C8 and C18 chemistries, the new product offers high resolution, stability and scalability for demanding peptide separations. It can be used during multiple stages of purification to address diverse impurity profiles and specific process requirements.

DuPont’s latest launch can also be integrated with its existing chromatography technologies, including AmberChrom XT, AmberChrom TQ1 and CG resins. Combining silica-based and polymeric chromatography technologies with a single purification workflow enables manufacturers to optimize purity, yield and recovery across multiple stages.

The launch reinforces DuPont’s focus on expanding its solutions to address evolving needs by offering process development and manufacturing scale-up to optimize purification workflows and achieve purity targets.

Shares of DD have lost 44.4% over the past year against the 1.2% rise of its industry. 

Image Source: Zacks Investment Research

DD’s Zacks Rank & Key PicksDDcurrently carries a Zacks Rank #3 (Hold).

Better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Cabot Corporation (CBT - Free Report) and Avient Corporation (AVNT - Free Report) .

RS currently sports a Zacks Rank #1 (Strong Buy), while CBT and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.70 per share, indicating a 66.2% year-over-year surge. RSshares have gained 50.8% over the past year.

The Zacks Consensus Estimate for CBT’s current fiscal-year earnings is pinned at $6.35 per share. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 4.56%. CBTshares have gained 4.2% over the past year.

The Zacks Consensus Estimate for AVNT’s 2026 earnings is pegged at $3.2 per share, indicating a year-over-year rise of 13.48%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.

New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final polishing WILMINGTON, Del., Oct. 22, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide therapeutics, including glucagon-like peptide-1 ( GLP-1 ) receptor agonists.

Krilogy Financial LLC lifted its position in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 615.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,638 shares of the basic materials company’s stock after purchasing an additional 20,333 shares during the period. Krilogy Financial LLC’s holdings in DuPont de Nemours were worth $3,070,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Nalls Sherbakoff Group LLC bought a new stake in DuPont de Nemours in the 4th quarter worth about $29,000. Elevation Wealth Partners LLC lifted its position in shares of DuPont de Nemours by 168.5% during the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock worth $32,000 after buying an additional 150 shares in the last quarter. Bangor Savings Bank bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $36,000. Grove Bank & Trust bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $40,000. Finally, Coastline Trust Co purchased a new position in shares of DuPont de Nemours in the 3rd quarter worth approximately $44,000. 73.96% of the stock is owned by institutional investors.

DuPont de Nemours Trading Down 0.9% Shares of DD stock opened at $128.41 on Thursday. The company’s fifty day simple moving average is $133.78 and its two-hundred day simple moving average is $138.29. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.43 and a quick ratio of 1.82. DuPont de Nemours, Inc. has a 1 year low of $97.34 and a 1 year high of $157.98. The stock has a market capitalization of $17.34 billion, a price-to-earnings ratio of 285.42, a PEG ratio of 1.18 and a beta of 1.05.

DuPont de Nemours (NYSE:DD – Get Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the business posted $1.12 earnings per share. The business’s quarterly revenue was up 4.0% on a year-over-year basis. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, analysts anticipate that DuPont de Nemours, Inc. will post 7.26 earnings per share for the current year. DuPont de Nemours Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a yield of 1.9%. DuPont de Nemours’s dividend payout ratio is 533.33%.

Wall Street Analysts Forecast Growth A number of equities analysts have recently weighed in on DD shares. The Goldman Sachs Group cut their target price on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $172.00 to $145.00 in a research report on Friday, October 9th. Zacks Research lowered DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. Royal Bank Of Canada dropped their price target on DuPont de Nemours from $180.00 to $176.00 and set an “outperform” rating on the stock in a report on Friday, August 7th. Finally, UBS Group cut their price objective on DuPont de Nemours from $178.00 to $172.00 and set a “buy” rating on the stock in a research report on Monday, October 5th. Twelve analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $163.00.

View Our Latest Research Report on DuPont de Nemours

DuPont de Nemours Company Profile (Free Report)

DuPont de Nemours, Inc is a science and technology company that develops engineered materials, specialty chemicals and other performance solutions for industrial and consumer markets. Its products are used in areas including electronics and semiconductor manufacturing, water purification, healthcare, transportation, construction, aerospace, worker safety and industrial processing.

DuPont’s portfolio includes well-known brands and materials such as Kevlar aramid fiber, Nomex flame-resistant materials, Tyvek protective materials, Kapton polyimide film, Vespel high-performance parts and Corian solid-surface materials.

Featured Articles Five stocks we like better than DuPont de Nemours Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.

GAMMA Investing LLC lifted its position in DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 242.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,978 shares of the basic materials company’s stock after buying an additional 19,096 shares during the period. GAMMA Investing LLC’s holdings in DuPont de Nemours were worth $3,504,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of DD. State Street Corp lifted its holdings in DuPont de Nemours by 140.3% in the second quarter. State Street Corp now owns 44,941,824 shares of the basic materials company’s stock valued at $6,095,909,000 after acquiring an additional 26,238,300 shares during the period. Auto Owners Insurance Co boosted its position in DuPont de Nemours by 4,275.8% in the fourth quarter. Auto Owners Insurance Co now owns 17,552,405 shares of the basic materials company’s stock worth $70,561,000 after purchasing an additional 17,151,278 shares during the last quarter. Fred Alger Management LLC bought a new stake in shares of DuPont de Nemours during the 4th quarter valued at about $96,068,000. Pacer Advisors Inc. grew its stake in shares of DuPont de Nemours by 3,951.2% during the 4th quarter. Pacer Advisors Inc. now owns 1,818,000 shares of the basic materials company’s stock valued at $73,084,000 after purchasing an additional 1,773,124 shares during the period. Finally, KBC Group NV increased its position in shares of DuPont de Nemours by 435.8% during the 1st quarter. KBC Group NV now owns 1,687,376 shares of the basic materials company’s stock valued at $77,281,000 after purchasing an additional 1,372,435 shares during the last quarter. Institutional investors own 73.96% of the company’s stock.

Analyst Ratings Changes DD has been the topic of several recent research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Monday, August 3rd. JPMorgan Chase & Co. boosted their target price on shares of DuPont de Nemours from $171.00 to $172.00 and gave the company an “overweight” rating in a research report on Monday, August 10th. Royal Bank Of Canada reduced their target price on shares of DuPont de Nemours from $180.00 to $176.00 and set an “outperform” rating for the company in a report on Friday, August 7th. The Goldman Sachs Group decreased their price target on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research report on Wednesday, September 30th. Finally, Zacks Research cut shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $165.27.

Get Our Latest Stock Analysis on DD DuPont de Nemours Trading Up 1.0% Shares of NYSE:DD opened at $132.40 on Friday. The stock has a 50 day moving average of $134.80 and a 200 day moving average of $138.48. The company has a market cap of $17.88 billion, a PE ratio of 294.29, a price-to-earnings-growth ratio of 1.20 and a beta of 1.05. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. DuPont de Nemours, Inc. has a 12-month low of $92.49 and a 12-month high of $157.98.

DuPont de Nemours (NYSE:DD – Get Free Report) last released its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter last year, the business earned $1.12 EPS. The firm’s revenue was up 4.0% compared to the same quarter last year. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, equities research analysts expect that DuPont de Nemours, Inc. will post 7.26 EPS for the current year.

(Free Report)

DuPont de Nemours, Inc is a science and technology company that develops engineered materials, specialty chemicals and other performance solutions for industrial and consumer markets. Its products are used in areas including electronics and semiconductor manufacturing, water purification, healthcare, transportation, construction, aerospace, worker safety and industrial processing.

DuPont’s portfolio includes well-known brands and materials such as Kevlar aramid fiber, Nomex flame-resistant materials, Tyvek protective materials, Kapton polyimide film, Vespel high-performance parts and Corian solid-surface materials.

Read More Five stocks we like better than DuPont de Nemours Want Private-Market Access to Kalshi and Polymarket? Try This ETF Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.

DuPont de Nemours (NYSE:DD – Get Free Report) and Marubeni (OTCMKTS:MARUY – Get Free Report) are both large-cap industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Profitability This table compares DuPont de Nemours and Marubeni’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets DuPont de Nemours 0.67% 6.92% 4.44% Marubeni 6.62% 13.08% 5.64% Insider & Institutional Ownership 74.0% of DuPont de Nemours shares are owned by institutional investors. Comparatively, 0.1% of Marubeni shares are owned by institutional investors. 1.0% of DuPont de Nemours shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Dividends DuPont de Nemours pays an annual dividend of $2.40 per share and has a dividend yield of 1.8%. Marubeni pays an annual dividend of $0.56 per share and has a dividend yield of 1.8%. DuPont de Nemours pays out 533.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Marubeni pays out 24.6% of its earnings in the form of a dividend. Marubeni is clearly the better dividend stock, given its higher yield and lower payout ratio. Risk & Volatility DuPont de Nemours has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, Marubeni has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

Analyst Recommendations This is a summary of recent ratings for DuPont de Nemours and Marubeni, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DuPont de Nemours 1 4 12 0 2.65 Marubeni 0 2 0 0 2.00 DuPont de Nemours currently has a consensus price target of $165.80, indicating a potential upside of 25.33%. Given DuPont de Nemours’ stronger consensus rating and higher probable upside, equities research analysts plainly believe DuPont de Nemours is more favorable than Marubeni.

Earnings & Valuation This table compares DuPont de Nemours and Marubeni”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DuPont de Nemours $6.99 billion 2.56 -$779.00 million $0.45 293.98 Marubeni $54.91 billion 0.93 $3.59 billion $2.28 13.51 Marubeni has higher revenue and earnings than DuPont de Nemours. Marubeni is trading at a lower price-to-earnings ratio than DuPont de Nemours, indicating that it is currently the more affordable of the two stocks.

(Get Free Report)

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, and electroless and electrolytic metallization solutions, and electromagnetic shielding and thermal management solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for organic light emitting diode, and other display applications; provides high performance parts, and specialty silicone elastomers, and lubricants to automotive, aerospace, electronics, industrial, and healthcare markets; and photopolymer plates and platemaking systems used in flexographic printing, and digital inks for textile, commercial, and home-office printing applications. The Water & Protection segment provides engineered products and integrated systems for worker safety, water purification and separation, transportation, energy, medical packaging and building materials. The Corporate & Other segment offers auto adhesives and fluids; Multibase; and Tedlar products. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.

About Marubeni (Get Free Report)

Marubeni Corporation engages in various business activities. It manufactures, wholesales, and retails apparel, footwear, home furnishing and sport goods, industrial and textile materials, tire and rubber materials, and household and nursing care products; develops uranium, nuclear fuel cycle, iron ore, coking coal, copper mines, and related equipment and services; smelts and refines aluminum and magnesium; leases temporary steel construction materials; explores for, develops, and produces oil and gas; manages infrastructure funds; and develops and manages real estate. The company also offers insurance, technical, ICT, and logistic services; agri-inputs; fertilizer and crop protection product contracting services; crop protection product formulations; wood chips, biomass fuels, pulp and waste papers, paper, paperboards, sanitary, and building and construction materials; engineering, procurement, and construction services; and operation and maintenance services. It trades in fertilizers, dairy, agricultural, and marine products; sugar, processed food, beverages raw materials, and commercial use food materials; grains, oilseeds, feed ingredients, compound feeds, fresh and processed meat, petrochemicals, plastics, salts, chlor-alkalis, life science products, electronic materials, fertilizer materials, and inorganic mineral resources and chemicals; steelmaking raw materials, ferroalloys, nonferrous metals, and steel products; cement and ingots related materials; and petroleum and LPG. The company engages in infrastructure; water; automotive finance; power generation; power service and retail; natural gas; hydrogen; and fuel ammonia businesses. It owns, purchases, operates, leases, sells, and charters aerospace and ship products; leases refrigerated trailers, commercial vehicles, and freight cars; and sells, trades in, leases, finances, and services construction and industrial machinery, and mobility products. The company was founded in 1858 and is based in Tokyo, Japan.

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.

Awards recognize continued excellence in healthcare packaging initiatives that utilize Tyvek® material to help drive and promote sustainable innovation

, /PRNewswire/ -- DuPont (NYSE: DD) announced the winners of its global awards program, the Tyvek® Sustainable Healthcare Packaging Awards, during the Medical Packaging Conference (MPC) hosted by DuPont September 30 - October 2, 2026, in Boston. Now in its third year, this awards program recognizes leaders across the healthcare industry who are embracing and driving sustainability throughout the packaging lifecycle.

The three 2026 winners, who utilize healthcare packaging made with DuPont™ Tyvek® material and whose efforts show a significant focus on sustainability in the three award categories, are:

Packaging (re)Design: Plastic Ingenuity
Plastic Ingenuity developed a new ready-to-use (RTU) tub and lid platform made from recycled PuraForm™ 134 polyester, offering an alternative to injection-molded polystyrene. Paired with Tyvek®, the design cuts plastic use by 15 percent and avoids 217 metric tons of CO2e per 1 million units, while staying recyclable. This helps manufacturers implement a solution made from materials that generate fewer particulates while providing a more sustainable solution.

Operational Efficiencies: Coligroup Spa
Coligroup redesigned traditional suture packaging to eliminate an entire layer of material while preserving full sterility. Relying solely on an aluminum inner pouch fitted with a strip made of Tyvek®, the solution lets sterilizing gas fully penetrate the package, removing the need for a second outer layer. This cuts material, labor and sterilization costs by up to 35 percent.

Sustainability In-Use: Nelipak Healthcare Packaging
Nelipak Healthcare Packaging developed Ecovate™ headerbags, an all-polyethylene laminate combining mono-axially oriented PE (MOPE) with Tyvek® with Renewable Attribution, replacing the mixed-material laminates common across the ready-to-fill/use (RTF/U) market. The mono-material structure is certified recyclable by Institut Cyclos-HTP and could lower the product's greenhouse gas footprint up to 40 percent when including end of life recycling, helping the growing RTF/U market advance packaging circularity.

"This year's winners demonstrate that sustainable healthcare packaging progress is happening through practical design choices, operational improvements and scalable material innovations," said Lesley Aulick, global business director, DuPont™ Tyvek® Roll Goods. "We are honored Tyvek® has a role in these initiatives and are committed to continued advancement of circularity, reducing environmental impact and supporting sustainability goals – all while protecting products and helping to ensure patient safety."

The Tyvek® Sustainable Healthcare Packaging Awards program further supports the Tyvek® Healthcare Packaging team's work to help advance DuPont's global strategy of working across the supply chain to help enable a more circular economy.

The awards program is open to any medical device and/or pharmaceutical manufacturer, sterile packaging manufacturer, healthcare facility, university, material recovery facility, or other healthcare company focused on sustainable packaging made with DuPont™ Tyvek® material. The next application period is expected to open in 2027, and more information on how to apply as well as current and previous winners can be found on the Tyvek® Sustainable Healthcare Packaging Awards website.

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and Tyvek® are owned by affiliates of DuPont de Nemours, Inc.
PuraForm™ is owned by Plastic Ingenuity. Ecovate™ is owned by Nelipak Healthcare Packaging.

SOURCE DuPont

Key Takeaways DuPont launched a digital tool to help sugar and sweetener makers evaluate chromatographic separation options.The Sugar Separation Advisor predicts chromatograms and suggests AmberLite resins for further testing.DuPont raised its 2026 guidance after Q2 outperformance, citing stronger EBITDA and adjusted earnings. DuPont de Nemours, Inc.(DD - Free Report) is strengthening its position in the specialty chemicals market with the launch of the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers evaluate chromatographic separation opportunities and identify suitable DuPont AmberLite resins for further testing. 

DuPont, which is among the prominent players in the chemical space alongside Dow Inc. (DOW - Free Report) , Eastman Chemical Company (EMN - Free Report) and Celanese Corporation (CE - Free Report) , is focusing on innovation, productivity and growth across healthcare, water and industrial markets. The company's latest digital initiative expands access to its chromatography expertise and experimental separation data, while its broader portfolio includes solutions for healthcare, industrial water, food and beverage and other industrial applications. 

The DuPont Sugar Separation Advisor builds on decades of chromatography application expertise and years of experimental separation data. The tool enables users to select a target sugar or sweetener, add up to four additional sugars or impurities to represent their feed stream and generate a predicted chromatogram based on experimental separation data. It then provides a qualitative separation assessment and suggests candidate DuPont AmberLite chromatography resins for further evaluation. 

According to DuPont, the platform is designed to simplify the early stages of separation evaluation by helping customers identify promising resin options and focus laboratory testing. This could support manufacturers evaluating applications ranging from high-fructose corn syrup and beet sugar processing to rare sugars, oligosaccharides, polysaccharides and sugar alcohols. 

DuPont developed the tool in response to recurring customer questions involving sugars and sweeteners such as allulose, tagatose, sorbitol, oligosaccharides, xylose and inositol. The resource displays laboratory-generated separation data for relevant sugar and resin combinations, helping users assess resin performance in application-relevant scenarios. 

DuPont, in August, raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance following its second-quarter outperformance. The company now expects net sales of $7.16-$7.19 billion, operating EBITDA of $1.75-$1.77 billion and adjusted earnings of $7.17-$7.32 per share. For the second half of 2026, DD projects net sales of $3.66-$3.69 billion, operating EBITDA of $890-$910 million and adjusted earnings of $3.65-$3.80 per share. 

Dow expects approximately $200 million in additional benefits from its Transform to Outperform program in 2026, taking total in-year benefits from self-help initiatives to more than $1.3 billion. In the second half, the company plans to focus on growth and innovation in attractive end markets, portfolio investments and balanced capital allocation. DOW expects productivity and growth benefits from the program to accelerate through the remainder of 2026 and into 2027. 

EastmanChemical expects 2026 earnings to improve significantly from 2025. Operating cash flow is projected to approach $900 million. For the third quarter, adjusted earnings are expected to be near the second-quarter level of $1.97 per share. Advanced Materials is expected to benefit from improved price-cost dynamics and asset utilization, while Fibers should gain from higher acetate tow purchases. 

Celanese expects third-quarter adjusted earnings of $1.35-$1.75 per share and continues to project 2026 adjusted earnings of approximately $6 per share. The company maintained its full-year free cash flow guidance of $700-$800 million. Growth initiatives, productivity measures and portfolio and footprint actions are expected to support 2026 performance and strengthen cash generation. 

SummaryDuPont is rated Buy, offering secular growth and margin expansion at an attractive valuation, with strong exposure to healthcare, water, EV, and aerospace markets.Healthcare and Water Technologies drive structural growth, supported by leading positions in medical devices and semiconductor water treatment, with resilient recurring revenues.The Diversified Industrials segment benefits from EV battery adhesives and aerospace, with growth initiatives and margin expansion through 80/20 simplification and productivity programs.DD trades below historical and sector valuation multiples, targeting 8–10% EPS growth and a 1.82% dividend yield, supporting a compelling risk-reward profile. Sundry Photography/iStock Editorial via Getty Images

Investment Thesis DuPont (DD) offers secular growth prospects and margin expansion opportunities at an attractive valuation. The company’s Healthcare and Water Technologies business should see structural growth, while its EV and aerospace business should

108 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Integrated Wealth Concepts LLC decreased its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 65.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,280 shares of the basic materials company’s stock after selling 13,713 shares during the period. Integrated Wealth Concepts LLC’s holdings in DuPont de Nemours were worth $987,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in DD. Geode Capital Management LLC increased its position in shares of DuPont de Nemours by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 11,019,892 shares of the basic materials company’s stock worth $441,285,000 after purchasing an additional 74,355 shares during the last quarter. Bank of America Corp DE increased its stake in DuPont de Nemours by 22.0% in the first quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company’s stock valued at $212,039,000 after acquiring an additional 835,572 shares during the last quarter. Bank of New York Mellon Corp raised its position in DuPont de Nemours by 10.0% during the first quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company’s stock valued at $169,762,000 after purchasing an additional 336,780 shares in the last quarter. Dimensional Fund Advisors LP raised its position in DuPont de Nemours by 4.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company’s stock valued at $160,688,000 after purchasing an additional 163,210 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new stake in DuPont de Nemours during the fourth quarter worth about $130,394,000. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets A number of equities analysts recently weighed in on the company. Citigroup raised their price objective on DuPont de Nemours from $168.00 to $170.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Royal Bank Of Canada cut their target price on DuPont de Nemours from $180.00 to $176.00 and set an “outperform” rating for the company in a research note on Friday, August 7th. The Goldman Sachs Group increased their price target on shares of DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings restated a “sell (d+)” rating on shares of DuPont de Nemours in a report on Monday, August 3rd. Finally, JPMorgan Chase & Co. upped their price objective on shares of DuPont de Nemours from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Monday, August 10th. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.60.

Check Out Our Latest Research Report on DD DuPont de Nemours Stock Performance Shares of NYSE:DD opened at $129.08 on Friday. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average price of $136.54 and a 200-day moving average price of $139.09. The company has a market cap of $17.43 billion, a price-to-earnings ratio of 286.89, a price-to-earnings-growth ratio of 1.17 and a beta of 1.06. DuPont de Nemours, Inc. has a 12 month low of $92.49 and a 12 month high of $157.98.

DuPont de Nemours (NYSE:DD – Get Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%.The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period last year, the firm earned $1.12 earnings per share. DuPont de Nemours’s quarterly revenue was up 4.0% on a year-over-year basis. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, equities analysts anticipate that DuPont de Nemours, Inc. will post 7.27 EPS for the current year.

DuPont de Nemours Cuts Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Monday, August 31st were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Monday, August 31st. DuPont de Nemours’s dividend payout ratio is currently 533.33%.

DuPont de Nemours Company Profile (Free Report)

DuPont de Nemours, Inc is a global materials science company headquartered in Wilmington, Delaware. The company develops engineered materials and specialty products used in electronics, transportation, construction, healthcare, water treatment, and industrial applications.

Its offerings include semiconductor and advanced packaging materials, engineering polymers, specialty resins, water purification and separation technologies, and protective materials and solutions. DuPont’s products are sold to manufacturers, industrial customers, and other businesses across North America, Europe, Asia-Pacific, and other international markets.

The company was formed in 2019 following the separation of DowDuPont into independent companies, including DuPont, Dow, and Corteva.

Featured Articles Five stocks we like better than DuPont de Nemours J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning 2 Stocks Breaking Out Post-FOMC With One Thing in Common Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways DuPont's healthcare, water, aerospace and EV exposure supported 4% organic sales growth in Q2.Spectrum Plastics and Donatelle Plastics acquisitions strengthen DuPont's healthcare exposure and innovation.DuPont targets $90 million in 2026 pricing to offset higher input costs and limit margin pressure. DuPont de Nemours, Inc. (DD - Free Report) benefits from its innovation-driven investment, productivity actions and acquisitions amid uneven construction demand and persistent cost pressure.

DD’s shares are down 45.6% in the past year compared to the Zacks Chemicals Diversified industry’s 3.3% decline.

Image Source: Zacks Investment Research

Let’s find out why DD stock is worth retaining at the moment.

Productivity, Innovation & Acquisitions Aid DD StockDuPont remains focused on organic growth through innovation, commercial execution and targeted acquisitions. Its innovation-driven investment is focused on several high-growth areas. DD's portfolio is exposed to healthcare, water, aerospace and electric vehicle (EV) applications, which supported 4% organic sales growth in second-quarter 2026. The company is expanding its innovation pipeline through direct lithium extraction solutions in Water, Liveo products for biopharma and new solutions for electric vehicles and battery energy storage.

The acquisition of Spectrum Plastics Group, a leading manufacturer of specialty medical devices and components, strengthened DuPont’s position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market. The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments.

DD said in August 2026 that it still had more than $1 billion available for potential mergers and acquisitions and was evaluating opportunities in water and healthcare. It also indicated that prospective acquisitions should add to the company’s growth algorithm and meet disciplined return thresholds. These actions support a more focused portfolio while retaining flexibility for selective growth investments and shareholder returns.

DuPont is also benefiting from cost synergy savings and productivity improvement actions. Its operating system is producing measurable cost and execution gains. In second-quarter 2026, net productivity improved and contributed to operating leverage. Management is targeting net productivity equal to 3% of cost of goods sold and expects to reach that run rate within about 18 months from August 2026. The 80/20 program is also moving from pilot work to implementation across four Diversified Industrials businesses, with a few million dollars of EBITDA benefit expected in second-half 2026. Full-year 2026 operating EBITDA guidance of $1.75-$1.77 billion implies continued benefits from organic growth and productivity.

Construction and Cost Headwinds Weigh On DuPontDuPont’s Building Technologies business remains exposed to a mixed construction backdrop. Organic sales rose in the low single digits in the second quarter as residential and non-residential demand improved, led by Asia Pacific, but management said single-family housing remained soft.

DD expects Building Technologies sales to increase only slightly for full-year 2026, indicating that the broader recovery remains limited. The company also noted that residential performance was above its underlying market in second-quarter 2026, which may make sustained growth more dependent on favorable market mix and end-market stabilization. This leaves Diversified Industrials exposed to uneven construction conditions even as aerospace and EV applications provide offsets.

Higher oil and gas-related input costs remain a margin drag in 2026 even though DuPont expects pricing to offset the dollar impact. Management said about $90 million of pricing is planned for full-year 2026, with most of it in the second half. Price-cost dynamics reduced second-quarter 2026 operating EBITDA margin by 30 basis points. The company expects a 50-basis-point margin drag in second-half 2026 and a 30-basis-point drag for the full year.

DD’s Zacks Rank & Other Key PicksDD currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Innospec Inc. (IOSP - Free Report) and Avient Corporation (AVNT - Free Report) .

While RS currently sports a Zacks Rank #1 (Strong Buy), IOSP and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. The consensus estimate for RS’s 2026 earnings has moved up 30.8% over the past 60 days.

The Zacks Consensus Estimate for IOSP’s current-year earnings is pegged at $5.03 per share, implying a 4.55% year-over-year decrease. Its earnings beat the Zacks Consensus Estimate in all of the trailing four quarters, with the average surprise being 12.9%.

The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.

Key Takeaways DuPont launches Tyvek with Renewable Attribution globally for Consumer & Industrial applications.Renewable attribution ranges from 30% to 100%, using ISCC PLUS-certified bio-circular materials.At 30% attribution, Tyvek supports about a 30% carbon-footprint reduction compared with standard Tyvek. DuPont de Nemours, Inc. (DD - Free Report) announced an expansion of its bio-circular materials portfolio with the global launch of Tyvek with Renewable Attribution for Consumer & Industrial (C&I) applications. The new offering enables customers to reduce the carbon footprint of products through Scope 3 emissions reduction without having to change existing designs or processes.

Tyvek with Renewable Attribution is designed for applications including active packaging, tags and labels, race bibs and wristbands, as well as industrial packaging such as art packaging, dunnage and industrial bags. The product is available with renewable attribution levels ranging from 30% to 100%, linked to ISCC PLUS-certified bio-circular materials through a mass-balance approach.

The renewable feedstocks are derived from second-generation biomass, including waste and residues that do not compete with food production. At the 30% renewable attribution level, the product supports an approximately 30% reduction in carbon footprint, including CO2 uptake, compared with standard Tyvek, based on peer-reviewed, ISO-compliant life-cycle assessment data.

Importantly, the new Tyvek offering is produced to the same specifications as conventional Tyvek, eliminating the need for requalification. This could facilitate faster and simpler adoption among existing customers. DuPont’s Luxembourg and Richmond manufacturing sites are ISCC PLUS-certified and undergo annual third-party audits. The launch supports the company’s broader sustainability strategy and efforts to advance circularity and reduce the environmental footprint of its products.

DD’s shares have lost 44.4% in the past year compared with the industry’s 2.7% decline in the same period.

Image Source: Zacks Investment Research

DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold)

Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) and Avient Corporation (AVNT - Free Report) .

While RS currently sports a Zacks Rank #1 (Strong Buy), APD and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.23 per share, indicating a 55.89% year-over-year increase. RS’ shares have gained 35.9% over the past year.

The Zacks Consensus Estimate for APD’s fiscal 2026 earnings is pegged at $13.46 per share, indicating a rise of 11.89% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing it in one, with an average surprise of 2.89%.

The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 14.2% over the past year.

Enabling customers to achieve more sustainable material sourcing without changing how they use Tyvek®

, /PRNewswire/ -- DuPont (NYSE: DD) today announced the global launch of Tyvek® with Renewable Attribution for Consumer & Industrial (C&I) applications, extending its certified bio-circular material innovation to customers in active packaging, tags and labels, race bibs and wristbands, as well as industrial packaging such as art packaging, dunnage and industrial bags.

As companies work to reduce its carbon footprint, including through Scope 3 emissions reduction, Tyvek® with Renewable Attribution offers a practical route to lower-carbon material sourcing. Most importantly, customers can transition to this innovative technology without redesigning their products or processes.

"Tyvek® with Renewable Attribution provides customers with a credible solution that maintains the performance they know while supporting progress on sustainable material sourcing and carbon footprint reduction. It is one step in the journey as we work towards implementing our sustainability strategy, and we will continue to go further as we work to reduce the environmental footprint of Tyvek® manufacturing and collaborate across the value chain to advance circularity of the product," said Jonathan Brunette, Sustainability Application Development Engineer, DuPont™ Tyvek® C&I.

Tyvek® with Renewable Attribution is available at renewable attribution levels from 30% to 100%, linked to ISCC PLUS-certified bio-circular material on a mass balance basis. Under this approach, certified bio-circular feedstocks are introduced and tracked within the upstream supply chain supporting a reduction in reliance on fossil feedstocks. The renewable feedstocks are then attributed to the purchased HDPE. The bio-circular feedstocks are derived from second-generation biomass, including waste and residues that do not compete with food production – resulting in more responsible material sourcing without placing additional pressure on agricultural resources or food supply chains.

Through the ISCC PLUS-certified mass balance approach, an equivalent amount of certified bio-circular feedstock is allocated to Tyvek® with Renewable Attribution. This enables customers to select a renewable attribution level from 30% to 100%1, with the carbon footprint reduction linked to the level chosen. At a 30% renewable attribution level, Tyvek® with Renewable Attribution supports an approximately 30% reduction in carbon footprint (including CO2 uptake) compared to standard Tyvek®, based on peer-reviewed, ISO-compliant life cycle assessment data.

Because Tyvek® with Renewable Attribution is produced to the same product specifications as conventional Tyvek®, customers can continue to rely on the same proven performance characteristics across their existing applications. This means they can take a measurable step toward more sustainable material sourcing and a reduced product carbon footprint without compromising durability, reliability or usability. Importantly, the product is a drop in solution, with no requalification needed, helping make adoption simpler and faster for existing Tyvek® users.

DuPont™ Tyvek® is an ISCC PLUS certificate holder at its Luxembourg and Richmond, Virginia manufacturing sites. As part of the voluntary ISCC PLUS certification process, which validates sustainability characteristics of alternative feedstocks across the value chain, the sites receive annual third-party audits and support transparent measurement, tracking and attribution of certified bio-circular feedstocks using the mass balance approach. This helps support traceability, feedstock identity, transparency and accurate renewable attribution. The launch also aligns with DuPont's wider sustainability strategy, including its 2035 Sustainability Goals and focus on enabling circularity, reducing environmental impact and supporting customers with innovative solutions that deliver direct sustainability advantages.

For more information on Tyvek® with Renewable Attribution, please visit https://www.dupont.com/consumer-and-industrial-applications/tyvek-with-renewable-attribution.html. 

About DuPont™ Tyvek® Consumer & Industrial
DuPont™ Tyvek® is a high-performance material that serves a wide range of consumer and industrial applications. Lightweight, durable, breathable, water-resistant and highly printable, Tyvek® combines reliable performance with creative flexibility.

Tyvek® is widely used in packaging, graphics, and consumer applications – including industrial and active packaging, wristbands, tags & labels, and consumer products, helping brands and manufacturers create solutions that stand out while delivering reliable protection and durability.

Driven by science-based innovation and global expertise, Tyvek® works closely with Consumer & Industrial partners to bring ideas to life with confidence and consistency.

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. © 2026 DuPont.

1 For active packaging, Tyvek® with Renewable Attribution is currently available up to 30% Renewable Attribution on HealthCare styles.

SOURCE DuPont

California State Teachers Retirement System boosted its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 7,560.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,660,655 shares of the basic materials company’s stock after purchasing an additional 38,156,004 shares during the period. California State Teachers Retirement System owned about 28.63% of DuPont de Nemours worth $5,243,931,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in DD. Auto Owners Insurance Co grew its stake in shares of DuPont de Nemours by 4,275.8% in the 4th quarter. Auto Owners Insurance Co now owns 17,552,405 shares of the basic materials company’s stock valued at $70,561,000 after purchasing an additional 17,151,278 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in DuPont de Nemours by 12,133.4% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 9,614,878 shares of the basic materials company’s stock valued at $365,921,000 after buying an additional 9,536,283 shares in the last quarter. Invesco Ltd. boosted its stake in DuPont de Nemours by 64.4% in the 4th quarter. Invesco Ltd. now owns 14,514,600 shares of the basic materials company’s stock valued at $583,487,000 after buying an additional 5,686,490 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its position in DuPont de Nemours by 242.4% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 7,491,426 shares of the basic materials company’s stock valued at $301,155,000 after acquiring an additional 5,303,219 shares during the period. Finally, Eurizon Capital SGR S.p.A. bought a new stake in DuPont de Nemours in the fourth quarter valued at $130,394,000. 73.96% of the stock is owned by institutional investors and hedge funds.

DuPont de Nemours Trading Down 2.6% Shares of DD opened at $127.94 on Thursday. The stock has a fifty day moving average price of $138.05 and a two-hundred day moving average price of $140.18. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.43. DuPont de Nemours, Inc. has a 52-week low of $92.49 and a 52-week high of $157.98. The company has a market cap of $17.28 billion, a price-to-earnings ratio of 284.36, a PEG ratio of 1.20 and a beta of 1.06.

DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.76 by $0.12. The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.81 billion. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%.The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. Analysts predict that DuPont de Nemours, Inc. will post 7.27 EPS for the current fiscal year. DuPont de Nemours Cuts Dividend The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be given a dividend of $0.60 per share. The ex-dividend date is Monday, August 31st. This represents a $2.40 annualized dividend and a yield of 1.9%. DuPont de Nemours’s dividend payout ratio is 533.33%.

Wall Street Analysts Forecast Growth Several research analysts have issued reports on the company. JPMorgan Chase & Co. lifted their price objective on DuPont de Nemours from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Monday, August 10th. Royal Bank Of Canada lowered their target price on shares of DuPont de Nemours from $180.00 to $176.00 and set an “outperform” rating on the stock in a report on Friday, August 7th. Zacks Research cut shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Citigroup lifted their price target on shares of DuPont de Nemours from $168.00 to $170.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Finally, The Goldman Sachs Group boosted their price target on shares of DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, DuPont de Nemours currently has a consensus rating of “Moderate Buy” and an average price target of $166.60.

Check Out Our Latest Stock Report on DuPont de Nemours

DuPont de Nemours Company Profile (Free Report)

DuPont de Nemours, Inc is a global materials science company headquartered in Wilmington, Delaware. The company develops engineered materials and specialty products used in electronics, transportation, construction, healthcare, water treatment, and industrial applications.

Its offerings include semiconductor and advanced packaging materials, engineering polymers, specialty resins, water purification and separation technologies, and protective materials and solutions. DuPont’s products are sold to manufacturers, industrial customers, and other businesses across North America, Europe, Asia-Pacific, and other international markets.

The company was formed in 2019 following the separation of DowDuPont into independent companies, including DuPont, Dow, and Corteva.

Featured Articles Five stocks we like better than DuPont de Nemours Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer Sovereign AI: Palantir and Nebius Cut the Cloud Cord Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.

GRAND RAPIDS, Mich., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flow Cleanrooms & Supply today announces the expanded availability of DuPont™ Tyvek® IsoClean® and DuPont™ Tyvek® 400 garments, providing customers with industry-leading contamination control solutions for sterile and controlled environments.

As an authorized distributor of DuPont™ Tyvek® IsoClean® and DuPont™ Tyvek® 400 products, Flow Cleanrooms & Supply offers a comprehensive selection of cleanroom apparel, including hoods, sleeves, coveralls, and boot covers. Designed for pharmaceutical, biotechnology, and other critical manufacturing applications, both product families are made with DuPont™ Tyvek®, a flash-spun material that provides an inherent barrier to particles, microorganisms, and non-hazardous liquid splashes while remaining lightweight and breathable for all-day comfort.

To support uninterrupted cleanroom operations, Flow Cleanrooms & Supply maintains inventory of key DuPont™ Tyvek® IsoClean® and DuPont™ Tyvek® 400 products for immediate availability. With stocked inventory and fast shipping capabilities, customers benefit from quick turnaround times and dependable access to cleanroom garments they need.

“Providing our customers with trusted contamination control solutions is at the core of what we do,” said Dustin Deckrow, President, Flow Cleanrooms & Supply. “By offering best-in-class DuPont™ supplies and maintaining inventory for rapid fulfillment, we enable our customers to stay compliant, prepared, and productive.”

For more information about Flow Cleanrooms & Supply’s catalog of DuPont™ Tyvek® cleanroom garments, visit Flowcleanrooms.com/dupont.

Media Contact:
Katie Kiley Brown
Modular Devices
[email protected]

About Flow Cleanrooms & Supply

Flow Cleanrooms & Supply provides turnkey and custom comprehensive modular cleanroom systems, as well as cleanroom supplies, equipment, and furniture, to meet the infrastructure and compliance needs of the world’s most demanding industries. From concept to cleanroom, Flow Cleanrooms & Supply is dedicated to helping customers maintain compliant, efficient, and contamination-free operations through high-quality products, expert support, and responsive service. More information: Flowcleanrooms.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

This information is based upon technical data that DuPont believes to be reliable. It is subject to revision as additional knowledge and experience become available. It is the user’s responsibility to determine the level of toxicity and the proper personal protective equipment needed. The information set forth herein reflects laboratory performance of fabrics, not complete garments, under controlled conditions. This information is intended for use by persons having the technical expertise to undertake evaluation under their own specific end-use conditions, at their own discretion and risk. Anyone intending to use this information should first check that the garment selected is suitable for the intended use. The end-user should discontinue use of garment if fabric becomes torn, worn or punctured, to avoid potential chemical exposure. Since conditions of use are beyond our control, DUPONT DE NEMOURS, INC. AND ITS AFFILIATES MAKE NO WARRANTIES, EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE AND ASSUME NO LIABILITY IN CONNECTION WITH ANY USE OF THESE PRODUCTS AND INFORMATION. This information is not intended as a license to operate under or a recommendation to infringe any trademark, patent or technical information of DuPont or other persons covering any material or its use.

© 2026 DuPont. All rights reserved. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/de8035e5-cd78-403d-ad5c-2c4a211c1305

Recognition highlights the collaborative efforts behind DuPont's recently launched end-to-end direct lithium extraction portfolio, helping accelerate the development of lithium resources needed for electrification and energy storage.

, /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Direct Lithium Extraction (DLE) team has been named a "Sustainability Squad" in the Business Intelligence Group's 2026 Sustainability Awards. The DuPont DLE team was recognized for its work over the past year helping develop, validate, and commercialize direct lithium extraction technologies that support effective and efficient lithium recovery and support scalable lithium production amid accelerating global demand.

Announced in July 2026, DuPont's end-to-end DLE portfolio comprises more than 20 products across multiple technologies, including lithium-selective sorbents, nanofiltration and reverse osmosis membranes, and ion exchange resins. Designed to address the complexity and variability of lithium brine resources around the world, the portfolio allows customers to implement complete end-to-end solutions or select individual technologies tailored to their specific process requirements and brine compositions. A key differentiator is DuPont's ability to optimize the entire lithium extraction flowsheet rather than treating process steps in isolation.

The "Sustainability Squad" award recognizes the collaborative efforts of a global team, spanning research and development, technical service, commercial strategy, and marketing. Over the past year, the team supported customer pilots and projects across major lithium-producing regions while helping translate laboratory innovation into commercial solutions through testing, process modeling, piloting support, and application expertise.

"This recognition reflects the dedication of our global team working with the support of our collaborators across the industry to help bring DuPont's direct lithium extraction technologies to market," said Dr. Martin Deetz, Senior R&D Laureate, DuPont Water Solutions. "By combining lithium-selective sorbents, membranes, ion exchange resins, and technical expertise into a full end-to-end approach, we are helping customers optimize the entire lithium extraction process while addressing the unique challenges of lithium brine resources around the world. We're proud to see our team recognized for its contribution to the global energy transition."

As demand for lithium continues to grow, producers are seeking technologies that can efficiently recover lithium from a wide range of brine resources. Through its integrated DLE portfolio and technical expertise, DuPont helps customers evaluate, validate, and implement solutions designed for their specific process requirements, supporting the development of the lithium supply chains needed for electric vehicles and energy storage systems.

Learn more about DuPont's Direct Lithium Extraction portfolio at https://www.dupont.com/water/applications/direct-lithium-extraction-solutions.html.

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

SOURCE DuPont

A federal judge on Friday approved more than $2.5 billion of ‌settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also known as “forever chemicals.”

On August 05, 2026, DuPont de Nemours Inc (DD) shares rose 3.1% to a current price of $147.37. Over the past year, the stock has experienced significant volatil

New distribution alignment improves regional service, increases product availability, and provides continued support for the 2026 Nature in Motion color launch

, /PRNewswire/ -- DuPont™ Corian® Design today announced it has enhanced its distribution partnership with Hallmark Building Supplies, Inc. and Parksite, increasing coverage across key Mid-Atlantic and Midwest markets.

This updated distribution alignment reinforces DuPont's ongoing commitment to delivering reliable product availability, responsive customer support, and a strong regional service experience for Corian® Design customers.

"As customer needs continue to evolve, we regularly assess our distribution network to ensure we are well-positioned to provide the highest level of service, support, and product availability," said Condylia Courtney, Global Business Director, Corian® Design. "By extending our partnership with Hallmark and Parksite, we are investing in a stronger, more resilient distribution model that supports our customers' growth and long-term success."

Through this expanded network, customers will gain access to experienced regional teams, strong logistics capabilities, technical resources, and dedicated service support via Hallmark and Parksite.

Hallmark will support customers across Eastern Illinois, Southern Indiana, Kentucky, Southern Ohio, Southern Virginia, and West Virginia, while Parksite will serve customers throughout Pennsylvania, Delaware, Maryland, Northern Virginia, and Northeast West Virginia.

This new alignment is a purposeful shift to allow for uninterrupted access to Corian® products, samples, technical support, specification resources, and customer service.

Hallmark and Parksite will also continue to support the recent 2026 Nature in Motion color launch, a new collection of Corian® Solid Surface and Corian® Quartz aesthetics inspired by warmth, movement, and modern design flexibility.

For nearly 60 years, Corian® has been a trusted choice to help solve design challenges, enabling architects, designers, fabricators, and commercial customers around the world. DuPont remains focused on supporting these customers with premium materials, dependable service, and strong partnerships that help bring projects to life and create moments that matter.

Customers interested in learning more about Corian® Design product samples, distributor support, and the 2026 Nature in Motion Color Collection are encouraged to visit the Corian® Design website.

About Corian® Design
Corian® Design is a global organization which creates, manufactures, and markets advanced materials, products, and solutions for interior design and architecture, originating from a foundation of world-class technologies and expertise. Marketed under the Corian® brand and the Make your Space™ tagline, its materials, products, and solutions meet the most demanding requirements in terms of beauty, functionality, and durability. To learn more about Corian® Design: https://www.corian.com.

About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

SOURCE DuPont

Kohl's Stock Soars After Better-Than-Feared QuarterDuPont de Nemours NYSE: DD raised its full-year 2026 outlook after reporting second-quarter results that exceeded its prior guidance, supported by organic growth, productivity gains and cash-flow generation.

Chief Executive Officer Lori Koch said the company delivered 4% organic sales growth, 80 basis points of margin expansion and double-digit adjusted earnings-per-share growth during the quarter. DuPont also plans to begin a $250 million share-repurchase program in the third quarter.

Get DuPont de Nemours alerts:

MarketBeat Week in Review – 05/18 - 05/22The company completed its previously announced reverse stock split in June, and its GICS classification changed to industrial in July. Koch said the revised classification better reflects the company’s industrial portfolio following its transformation in recent years.

Second-Quarter Results Second-quarter net sales were $1.8 billion, up 4% from the prior-year period on 4% organic growth. Growth was broad-based, led by healthcare, aerospace, industrial water and semiconductor markets, Chief Financial Officer Antonella Franzen said. Building technologies also grew year over year, supported by residential and non-residential construction activity.

Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?Operating EBITDA rose 8% to $448 million, while operating EBITDA margin expanded 80 basis points to 24.6%. The margin result included a 30-basis-point headwind from price-cost dynamics, according to Franzen.

Adjusted EPS increased 21% year over year to $1.88. Franzen said stronger operations contributed $0.17 per share to the increase, while below-the-line items contributed another $0.15 per share.

Transaction-adjusted free cash flow totaled $326 million, producing 127% conversion during the quarter. The company said earnings growth and working-capital productivity supported the result.

Healthcare & Water Technologies: Sales rose 5% to $856 million, including 4% organic growth and a 1% currency benefit. Segment operating EBITDA increased 4% to $258 million, though margin declined 30 basis points to 30.1% due to mix and growth investments. Diversified Industrials: Sales rose 3% to $963 million, entirely from organic growth. Operating EBITDA increased 7% to $213 million, and margin rose 70 basis points to 22.1%. Within Healthcare & Water Technologies, healthcare sales increased at a mid-single-digit organic rate, with double-digit gains in personal protection and biopharma. Water sales grew at a low-single-digit rate, as double-digit growth in industrial water and semiconductor applications was partly offset by weakness in the Middle East.

Outside the Middle East, water organic sales increased at a mid-single-digit rate. Koch said the Middle East represents about 10% of water sales and that project timing has shifted due to the regional conflict, rather than any structural change in the market. The company expects most of the delayed project revenue to arrive in the fourth quarter.

Raised 2026 Guidance DuPont now expects full-year organic sales growth to be slightly above 4%. The company adjusted the midpoint of its sales outlook to $7.175 billion, reflecting a lower expected currency benefit as the U.S. dollar strengthens.

The company raised the midpoint of its operating EBITDA outlook to $1.760 billion and its adjusted EPS midpoint to $7.24, a $0.15 increase from its prior forecast. The adjusted EPS outlook would represent an 18% increase from the prior-year pro forma result.

Full-year operating EBITDA margin is expected to be 24.5%, including a 30-basis-point headwind from oil and gas inflation. DuPont expects full-year free-cash-flow conversion to be closer to 100% than its prior target of 90%, Franzen said.

For the second half, DuPont expects approximately 6% organic sales growth, including pricing actions already implemented. The company forecasts second-half sales of $3.675 billion and operating EBITDA of $900 million. Second-half operating EBITDA margin is expected to be 24.5%, including a 50-basis-point headwind from oil and gas inflation.

Third-quarter guidance calls for sales of $1.835 billion, operating EBITDA of $448 million and adjusted EPS of $1.80 to $1.90 per share. Reported third-quarter organic growth is expected to be about 3%, or about 5% after adjusting for a prior-year sales timing shift associated with systems activity before the Qnity separation.

Operational and Commercial Initiatives Koch said DuPont is integrating innovation, commercial excellence, operational excellence and 80/20 initiatives into a single business system intended to improve growth, margins and execution. The company reported more than a 100-basis-point improvement in on-time, in-full delivery during the quarter and said it is reducing its cost of poor quality.

DuPont’s cost of poor quality stands at about 4% of sales, compared with a benchmark of roughly 5%, Koch said. The company is targeting net productivity of 3% of cost of goods sold annually and expects to reach that run rate across the organization within about 18 months. Second-quarter productivity represented about a 200-basis-point reduction on a cost-of-goods-sold basis, contributing about 100 basis points of margin expansion as a percentage of revenue.

The company has also piloted 80/20 initiatives across four Diversified Industrials businesses. Koch said the work has identified opportunities to simplify product portfolios, improve manufacturing yield, optimize production sequencing and reallocate commercial and technical resources toward higher-growth markets. DuPont expects a few million dollars of EBITDA benefit in the second half from those efforts, primarily through margin improvement.

On the commercial side, DuPont said it has won about 150 opportunities through sales plays, representing a nearly 30% win rate compared with its historical rate in the high teens. Koch said artificial intelligence has accelerated the preparation and launch of sales plays, cutting the process from months to about four weeks, while commercial organization changes have supported the higher win rate.

Growth Markets and Capital Allocation Management cited continued momentum in aerospace, electric-vehicle batteries, industrial water and semiconductor applications. Industrial water sales to semiconductor customers, which provide ultrapure water for chip manufacturing, grew more than 20% and are expected to continue growing, Franzen said.

DuPont’s electric-vehicle battery business currently generates about $70 million in revenue, primarily from adhesives. Koch said the company expects the business to move into the triple-digit-million-dollar range in 2026 and 2027. More broadly, the company sees a several-hundred-million-dollar EV opportunity within its approximately $900 million automotive portfolio.

The company also introduced an integrated direct-lithium-extraction solution incorporating membranes and ion-exchange resins. Koch said the opportunity requires no incremental capital expenditure and estimated the direct-lithium-extraction market at about $200 million.

Alongside the planned buyback, DuPont said it retains more than $1 billion for potential acquisitions. Koch said the company sees an active pipeline in water and healthcare, including packaging and contract development and manufacturing opportunities, but will remain disciplined on valuation and expected returns.

About DuPont de Nemours (NYSE:DD)DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in DuPont de Nemours Right Now?Before you consider DuPont de Nemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.

While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

For the quarter ended June 2026, DuPont de Nemours (DD - Free Report) reported revenue of $1.82 billion, down 44.2% over the same period last year. EPS came in at $1.88, compared to $3.36 in the year-ago quarter.

The reported revenue represents a surprise of +0.06% over the Zacks Consensus Estimate of $1.82 billion. With the consensus EPS estimate being $1.76, the EPS surprise was +6.82%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how DuPont de Nemours performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Change in Net Sales - Healthcare & Water Technologies - Currency: 1% versus 0.3% estimated by two analysts on average.Change in Net Sales - Diversified Industrials - Total: 3% versus the two-analyst average estimate of 1.7%.Change in Net Sales - Healthcare & Water Technologies - Total: 5% versus 5.3% estimated by two analysts on average.Net sales- Diversified Industrials: $963 million versus the two-analyst average estimate of $946.87 million.Net sales- Healthcare & Water Technologies: $856 million compared to the $859.9 million average estimate based on two analysts.Operating EBITDA- Healthcare & Water Technologies: $258 million versus the two-analyst average estimate of $256.59 million.Operating EBITDA- Corporate: $-23 million compared to the $-31.56 million average estimate based on two analysts.Operating EBITDA- Diversified Industrials: $213 million versus the two-analyst average estimate of $205.21 million.View all Key Company Metrics for DuPont de Nemours here>>>

Shares of DuPont de Nemours have returned +0.2% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

DuPont de Nemours reported a higher profit in the second quarter as sales rose across the chemicals and materials company's segments.

Exceeds Second Quarter 2026 Guidance

Raises Full Year 2026 Guidance

Second Quarter 2026 Highlights

Net Sales of $1.8 billion increased 4%; organic sales increased 4% versus year-ago period GAAP Income from continuing operations of $191 million; operating EBITDA of $448 million GAAP EPS from continuing operations of $1.37; adjusted EPS of $1.88 Cash provided by operating activities from continuing operations of $400 million; transaction-adjusted free cash flow of $326 million representing 127% conversion Announces intent to repurchase $250 million of shares in the third quarter Announces the Company's Global Industry Classification Standard (GICS) code has changed to Industrials effective July 31, 2026 , /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the second quarter ended June 30, 2026 and raised financial guidance for the full year 2026. 

"We delivered another strong quarter, exceeding our financial guidance and demonstrating our focus on consistent execution" said Lori Koch, DuPont Chief Executive Officer. "Mid-single digit organic growth, strong margin expansion, coupled with robust adjusted EPS growth and free cash flow generation underscore the strength of our market-leading businesses and reflect disciplined execution of our strategic priorities, supported by our ongoing focus on excellence and productivity."

"We are delivering on our commitments, creating value for all of our key stakeholders and further strengthening the foundation for sustainable, long-term profitable growth," Koch concluded.

Second Quarter 2026 Consolidated Results(1)

Dollars in millions, except EPS

2Q'26

2Q'25

Change

vs. 2Q'25

Organic Sales (2)

vs. 2Q'25

Net sales

$1,819

$1,749

4 %

4 %

GAAP Income from continuing operations

$191

$24

n.m.

Operating EBITDA(2)

$448

$423

6 %

Operating EBITDA margin(2) %

24.6 %

24.2 %

40 bps

GAAP EPS from continuing operations

$1.37

$0.17

n.m.

Adjusted EPS(2)

$1.88

$1.27

48 %

Cash provided by operating activities – cont. ops.

$400

$74

n.m.

Transaction-adjusted free cash flow(2)

$326

$107

205 %

Net sales

Net sales were up 4% on a 4% increase in organic sales. 4% organic sales growth in Healthcare & Water Technologies; 3% organic sales growth in Diversified Industrials. GAAP Income from continuing operations

GAAP Income/GAAP EPS from continuing operations improved on higher segment earnings and lower interest expense and transaction costs. Operating EBITDA

Operating EBITDA increased on organic growth and productivity. Adjusted EPS

Adjusted EPS increased on higher segment earnings, lower net interest expense and a lower tax rate. Cash provided by operating activities from continuing operations

Cash provided by operating activities from continuing operations in the quarter of $400 million, capital expenditures of $76 million and separation-related transaction costs and other payments of $2 million resulted in transaction-adjusted free cash flow and related conversion of $326 million and 127%, respectively. (1)

Results and cash flows are presented on a continuing operations basis. See page 6 for further information, including the basis of presentation included in this release.

(2)

Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 6 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 13 of this communication.

Second Quarter 2026 Segment Highlights

Healthcare & Water Technologies

Dollars in millions

2Q'26

2Q'25

Change

vs. 2Q'25

Organic Sales(2)

vs. 2Q'25

Net sales

$856

$817

5 %

4 %

Operating EBITDA

$258

$248

4 %

Operating EBITDA margin %

30.1 %

30.4 %

(30) bps

Net sales

Net sales increased 5% on organic sales growth of 4% and a currency benefit of 1%. Healthcare Technologies sales up mid-single digits on an organic basis on broad-based growth led by personal protection and biopharma. Water Technologies sales up low-single digits on an organic basis on continued strength in industrial water and semiconductor markets, partially offset by weakness in the Middle East.    Operating EBITDA

Operating EBITDA increased on organic growth and productivity, partially offset by growth investments. Operating EBITDA margin of 30.1% decreased 30 basis points as organic growth and productivity were more than offset by less favorable mix and growth investments. Diversified Industrials

Dollars in millions

2Q'26

2Q'25

Change

vs. 2Q'25

Organic Sales(2)

vs. 2Q'25

Net sales

$963

$932

3 %

3 %

Operating EBITDA

$213

$199

7 %

Operating EBITDA margin %

22.1 %

21.4 %

70 bps

Net sales

Net sales increased 3% on organic sales growth in the quarter. Building Technologies sales up low-single digits on an organic basis due to growth in residential and non-residential construction markets. Industrial Technologies sales up mid-single digits on an organic basis on continued strength in aerospace coupled with growth in electric vehicle applications. Operating EBITDA

Operating EBITDA and margin increased on organic growth, favorable mix and productivity. 2026 Financial Outlook

Dollars in millions, except EPS

2H'26E

Full Year 2026E

Net sales

$3,660 - $3,690

$7,160 - $7,190

Operating EBITDA(2)

$890 - $910

$1,750 - $1,770

Adjusted EPS(2)

$3.65 - $3.80

$7.17 - $7.32

"Our strong execution and market-driven growth continue to translate into higher earnings and free cash flow generation. As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%," said Antonella Franzen, DuPont Chief Financial Officer.

"With continued strength across healthcare, industrial water, and aerospace end-markets, we expect mid-single digit organic sales growth in the second half and remain focused on driving profitable growth and value creation for shareholders." Franzen concluded.

Conference Call

The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont's Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont's Investor Relations Events and Presentations page following the live event.

About DuPont

DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

Overview

On May 26, 2026, DuPont's Board of Directors announced a reverse stock split of the Company's common stock, par value $0.01 per share, at a ratio of 1-for-3, as well as a reduction in the number of authorized shares of its common stock by a corresponding ratio (the "Reverse Stock Split"), as approved by shareholders. The Reverse Stock Split became effective on June 24, 2026. All share and share-related information presented in these interim Consolidated Financial Statements has been retroactively adjusted in all periods presented to reflect the decreased number of shares resulting from the Reverse Stock Split and related impacts.

On April 1, 2026, DuPont completed the sale of the Aramids business (the "Aramids Business" and the divestiture of the Aramids Business, the "Aramids Divestiture") to Arclin, a portfolio company of an affiliate of TJC LP for pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable in the principal amount of $300 million (the "Aramids Note Receivable") and a non-controlling common equity interest (the "Aramids Equity Consideration"), valued at $325 million, in New Arclin U.S. Holding Corp., which now owns the Arclin global materials business and the Aramids Business. The financial results of the divested Aramids Business are reflected in DuPont's interim Consolidated Financial Statements as discontinued operations, along with comparative periods.

On November 1, 2025, DuPont completed the separation of its semiconductor and interconnect solutions businesses (the "Electronics Business" and the separation of the Electronics Business, the "Electronics Separation") into an independent public company, Qnity Electronics, Inc. ("Qnity"), by way of the distribution to DuPont's stockholders of record as of October 22, 2025 of all the issued and outstanding common stock of Qnity on November 1, 2025 (the "Qnity Distribution"). As a result, the financial results of the divested Electronics Business are reflected in DuPont's interim Consolidated Financial Statements as discontinued operations for all periods.

Cautionary Statement Regarding Forward-looking Statements

Certain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) the ability to realize the intended benefits of the Electronics Separation and the Qnity Distribution, including achievement of the intended tax treatment, contractual allocation to, and assumption by Qnity of certain liabilities, including certain legacy liabilities with respect to per- and polyfluoroalkyl substances ("PFAS") and the possibility of disputes, litigation or unanticipated costs in connection with the Electronics Separation and Qnity Distribution; (ii) the impact of the Aramids Divestiture on DuPont's balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva, Inc. and The Chemours Company, including the outcome of pending or future litigation related to PFAS or PFOA, which includes personal injury claims and natural resource damages claims; the extent and cost of ongoing and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (iv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Electronics Separation, the Aramids Divestiture and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (v) risks and uncertainties that are outside the Company's control but adversely impact the overall environment in which DuPont, its customers and/or its suppliers operate, including changes in economic, political, regulatory, international trade, geopolitical, military conflicts, capital markets and other external conditions, including pandemics and responsive actions, as well as natural and other disasters or weather-related events; (vi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (vii) the risks and uncertainties associated with continuing or expanding geopolitical conflicts or trade disputes or restrictions and responsive actions, new or increased tariffs or export controls, including on exports to China of U.S.-regulated products and technology; (viii) other risks to DuPont's business and operations, including the risk of impairment; (ix) risks and uncertainties in connection with completing the $2 billion share buyback announced on November 6, 2025, including timeline, associated costs and the possibility that the authorization may be suspended or discontinued prior to completion; (x) the ability to realize the intended benefits of the Reverse Stock Split; (xi) the impact of the invalidation of certain tariffs imposed under the International Emergency Economic Powers Act and (xii) other risk factors discussed in DuPont's most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.

Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Non-GAAP Financial Measures

Unless otherwise indicated, all financial metrics presented reflect continuing operations only.

This communication includes information that does not conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont's management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these Non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 12. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Key Terms

Significant Items

Significant items are items that arise outside the ordinary course of business for the Company and includes items for nonconsolidated affiliates, that the Company's management believes may cause misinterpretation of underlying business and investment performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance. There were no significant items associated with nonconsolidated affiliates recorded for the three and six month periods ended June 30, 2026 and June 30, 2025.

Future Reimbursable Indirect Costs

Indirect costs, such as those related to corporate and shared service functions previously allocated to the separated Electronics Business and Aramids Business, do not meet the criteria for discontinued operations and are reported within continuing operations in all respective periods presented. The Company has, is, will or expects to be reimbursed in accordance with the applicable transition service agreements ("TSAs") for the portion of indirect costs related to activities the Company is, will or expects to undertake on a transitional basis to support a) Qnity not beyond year end 2027 for services and 2040 for site leases and, b) the Aramids Business post the Aramids Divestiture, but not beyond 2028 (such indirect costs "Future Reimbursable Indirect Costs"). Services provided and costs reimbursed in accordance with the applicable TSAs include but are not limited to, costs associated with information technology services/support, product stewardship and regulatory support, facilities services, and shared property lease costs.

Future Reimbursable Indirect Costs do not meet the criteria for discontinued operations and therefore are included in both GAAP Net Income from Continuing Operations and in GAAP Cash provided by operating activities-continuing operations for all periods presented. Future Reimbursable Indirect Costs are excluded from Adjusted Earnings, Operating EBITDA and Transaction-Adjusted Free Cash Flow, each defined below. Such indirect costs that are not subject to future reimbursement are reported within continuing operations in Corporate and are included within Adjusted Earnings, Operating EBITDA, and Cash provided by operating activities-continuing operations.

Corporate DDOB Remediation Costs

Corporate DDOB Remediation Costs are environmental remediation costs, including certain investigate, remediate and restoration costs, associated with discontinued or divested operations, businesses or product lines ("Corporate DDOB Remediation Costs"). DDOB Remediation Costs are excluded from Adjusted Earnings and Operating EBITDA, as defined below, to provide better insight into the underlying business performance of the Company.

Non-GAAP Measure Definitions

Organic Sales

Organic Sales is defined as net sales excluding the impacts of currency and portfolio.

Adjusted Earnings

Adjusted Earnings is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs, Future Reimbursable Indirect Costs and Corporate DDOB Remediation Costs.

Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.

Adjusted EPS

Adjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2026 associated with intangibles to be about $275 million on a pre-tax basis, or approximately $1.54 per share.

Operating EBITDA, EBITDA Margin & Incremental Margin

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, Corporate DDOB Remediation Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.

Incremental Margin is the change in Operating EBITDA divided by the change in Net Sales for the applicable period.

Adjusted Free Cash Flow & Adjusted Free Cash Flow Conversion

Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three and six month periods ended June 30, 2026.

Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.

Transaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow Conversion

Management believes supplemental non-GAAP financial measures including Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company's underlying business performance during this period of transformational change. Management believes the Electronics Separation and Aramids Divestiture collectively represent a significant transformational change for the Company and separation-related transaction cost payments impact comparability to the Company's continuing operations. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.

Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and removing the impact of separation-related transaction costs and other payment and cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity.

Transaction-Adjusted Free Cash Flow Conversion is defined as Transaction-Adjusted Free Cash Flow excluding separation-related transaction costs, divided by Adjusted Earnings.

Separation-related transaction costs and other payments include cash outflows directly associated with the Electronics Separation and the Aramids Divestiture. These costs include advisor and banking fees, payments related to establishing a new capital structure (including fees associated with interest rate swaps), capital expenditures required to facilitate physical asset separation, restructuring payments associated with senior leadership, and Future Reimbursable Indirect Costs, among other expenditures.

Future Reimbursable Indirect Costs are excluded from Adjusted Earnings and Operating EBITDA. To provide comparable data analysis, the Company has also adjusted payments associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments. This adjustment is intended to provide insight into the Company's underlying business performance. For the six months ended June 30, 2026, the Company adjusted $8 million associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments.

Additionally, $2 and $5 million were reflected in Separation-related transaction costs and other payments for the three and six month periods ended June 30, 2026, respectively, for capital expenditures incurred to complete the physical separation of shared locations.

Finally, $6 million of restructuring and short-term incentive program payments to former senior leadership were reflected in Separation-related transaction costs and other payments for the six month period ended June 30, 2026. These payments were reflected in other cash payments as they related to the establishment of the post-spin leadership structure.

DuPont de Nemours, Inc.

Consolidated Statements of Operations

Three Months Ended
June 30,

Six Months Ended

June 30,

In millions, except per share amounts (Unaudited)

2026

2025

2026

2025

Net sales

$    1,819

$    1,749

$    3,500

$    3,361

Cost of sales

1,180

1,143

2,259

2,212

Research and development expenses

42

53

89

103

Selling, general and administrative expenses

269

262

524

496

Amortization of intangibles

68

74

136

149

Restructuring and asset related (benefits) charges - net

(3)

—

43

39

Acquisition, integration and separation costs

7

55

7

105

Equity in earnings (loss) of nonconsolidated affiliates

9

9

8

(6)

Sundry income (expense) - net

42

(9)

78

91

Interest expense

41

84

81

167

Income from continuing operations before income taxes

$      266

$        78

$      447

$      175

Provision for income taxes on continuing operations

75

54

106

71

Income from continuing operations, net of tax

$      191

$        24

$      341

$      104

(Loss) income from discontinued operations, net of tax

(44)

46

(30)

(615)

Net income (loss)

$      147

$        70

$      311

$     (511)

Net income attributable to noncontrolling interests

4

11

7

19

Net income (loss) available for DuPont common stockholders

$      143

$        59

$      304

$     (530)

Per common share data:

Earnings per common share from continuing operations - basic

$     1.38

$     0.17

$     2.45

$     0.73

(Loss) earnings per common share from discontinued operations - basic

(0.32)

0.25

(0.22)

(4.53)

Earnings (loss) per common share - basic

$     1.05

$     0.42

$     2.23

$    (3.80)

Earnings per common share from continuing operations - diluted

$     1.37

$     0.17

$     2.43

$     0.73

(Loss) earnings per common share from discontinued operations - diluted

(0.32)

0.25

(0.22)

(4.52)

Earnings (loss) per common share - diluted

$     1.05

$     0.42

$     2.22

$    (3.79)

Weighted-average common shares outstanding - basic

135.9

139.6

136.3

139.6

Weighted-average common shares outstanding - diluted

136.8

139.9

137.2

139.9

DuPont de Nemours, Inc.

Condensed Consolidated Balance Sheets

In millions, except share amounts (Unaudited)

June 30, 2026

December 31, 2025

Assets

Current Assets

Cash and cash equivalents

$                  1,740

$                    715

Restricted cash and cash equivalents

42

42

Accounts and notes receivable - net

1,751

1,669

Inventories

1,210

1,172

Prepaid and other current assets

113

121

Assets of discontinued operations

—

1,856

Total current assets

$                  4,856

$                  5,575

Property, plant and equipment - net of accumulated depreciation (June 30,
2026 - $3,694; December 31, 2025 - $3,565)

3,379

3,464

Other Assets

Goodwill

7,840

7,915

Other intangible assets

2,789

2,936

Investments and noncurrent receivables

981

432

Deferred income tax assets

221

282

Deferred charges and other assets

995

971

Total other assets

$                 12,826

$                 12,536

Total Assets

$                 21,061

$                 21,575

Liabilities and Equity

Current Liabilities

Short-term borrowings

$                        —

$                       60

Accounts payable

978

995

Income taxes payable

53

54

Accrued and other current liabilities

970

882

Liabilities of discontinued operations

—

314

Total current liabilities

$                   2,001

$                  2,305

Long-Term Debt

3,125

3,134

Other Noncurrent Liabilities

Deferred income tax liabilities

295

405

Pension and other post-employment benefits - noncurrent

400

432

Other noncurrent obligations

1,359

1,196

Total other noncurrent liabilities

$                   2,054

$                  2,033

Total Liabilities

$                   7,180

$                  7,472

Commitments and contingent liabilities

Stockholders' Equity

Common stock (authorized 555,555,556 shares of $0.01 par value each;
issued 2026: 135,038,855 shares; 2025: 136,398,482 shares)

1

1

Additional paid-in capital

$                 38,710

38,721

Accumulated deficit

(24,326)

(24,278)

Accumulated other comprehensive loss

(616)

(525)

Total DuPont stockholders' equity

$                 13,769

$                 13,919

Noncontrolling interests

112

184

Total equity

$                 13,881

$                 14,103

Total Liabilities and Equity

$                 21,061

$                 21,575

DuPont de Nemours, Inc.

Consolidated Statement of Cash Flows

Six Months Ended June 30,

In millions (Unaudited)

2026

2025

Operating Activities

Net income (loss)

$                311

$               (511)

Loss from discontinued operations

(30)

(615)

Net income from continuing operations

$                341

$                104

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

309

326

Credit for deferred income tax and other tax related items

45

9

(Earnings) losses of nonconsolidated affiliates (in excess of) less than dividends received

(6)

7

Net periodic pension benefit costs

6

2

Periodic benefit plan contributions

(28)

(23)

Restructuring and asset related charges - net

43

39

Interest rate swap gain

—

(51)

Stock based compensation

27

22

Donatelle contingent earn-out true-up

(14)

(12)

Other net (income) loss

(2)

16

Changes in assets and liabilities, net of effects of acquired and divested companies:

Accounts and notes receivable

(88)

(213)

Inventories

(29)

(51)

Accounts payable

92

(19)

Other assets and liabilities, net

(64)

(5)

Cash provided by operating activities - continuing operations

$                632

$                151

Investing Activities

Capital expenditures

(178)

(172)

Proceeds and adjustments to proceeds from sales of businesses, net of cash divested

1,158

—

Other investing activities, net

9

7

Cash provided by (used for) investing activities - continuing operations

$                989

$              (165)

Financing Activities

Changes in short-term borrowings

(60)

—

Purchases of common stock and forward contracts

(275)

—

Proceeds from issuance of Company stock

107

4

Employee taxes paid for share-based payment arrangements

(22)

(22)

Distributions to noncontrolling interests

(11)

(5)

Dividends paid to stockholders

(163)

(343)

Other financing activities, net

(1)

(7)

Cash used for financing activities - continuing operations

$              (425)

$              (373)

Cash Flows from Discontinued Operations

Cash (used for) provided by operations - discontinued operations

(158)

540

Cash used for investing activities - discontinued operations

(6)

(193)

Cash used for financing activities - discontinued operations

(3)

(17)

Cash (used for) provided by discontinued operations

$              (167)

$                330

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(7)

44

Increase (decrease) in cash, cash equivalents and restricted cash

$             1,022

$                (13)

Cash, cash equivalents and restricted cash from continuing operations, beginning of period

757

1,834

Cash, cash equivalents and restricted cash from discontinued operations, beginning of period

3

58

Cash, cash equivalents and restricted cash at beginning of period

$                760

$             1,892

Cash, cash equivalents and restricted cash from continuing operations, end of period

1,782

1,817

Cash, cash equivalents and restricted cash from discontinued operations, end of period

—

62

Cash, cash equivalents and restricted cash at end of period

$             1,782

$             1,879

DuPont de Nemours, Inc.

Select Segment Information and Non-GAAP Measures

Net Sales by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$          856

$          817

$        1,662

$        1,580

Diversified Industrials

963

932

1,838

1,781

Total

$        1,819

$        1,749

$        3,500

$        3,361

Net Sales Variance by Segment

Three Months Ended June 30, 2026

Organic Sales

Currency

Portfolio / Other

Total

Percent change from prior year (Unaudited)

Healthcare & Water Technologies

4 %

1 %

— %

5 %

Diversified Industrials

3

—

—

3

Total

4 %

— %

— %

4 %

Net Sales Variance by Segment

Six Months Ended June 30, 2026

Organic Sales

Currency

Portfolio / Other

Total

Percent change from prior year (Unaudited)

Healthcare & Water Technologies

3 %

2 %

— %

5 %

Diversified Industrials

2

1

—

3

Total

3 %

1 %

— %

4 %

Operating EBITDA by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$          258

$          248

$          502

$          471

Diversified Industrials

213

199

413

384

Corporate 1

(23)

(24)

(53)

(72)

Total

$          448

$          423

$          862

$          783

1.

Corporate includes expenses of the Corporate function not allocated to specific business in the Company.

Equity in Earnings (Loss) of Nonconsolidated Affiliates by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$             1

$            —

$             2

$            —

Diversified Industrials

—

—

(1)

—

Corporate 1

8

9

7

(6)

Total equity earnings (loss) included in operating EBITDA (GAAP)

$             9

$             9

$             8

$            (6)

1.

Corporate includes the equity interest acquired in the Delrin® Divestiture transaction.

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

Reconciliation of "Income from continuing operations, net of tax" to
"Operating EBITDA"

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Income from continuing operations, net of tax (GAAP)

$         191

$          24

$         341

$         104

+ Provision for income taxes on continuing operations

75

54

106

71

Income from continuing operations before income taxes

$         266

$          78

$         447

$         175

+ Depreciation and amortization

154

166

309

326

 - Interest income 1, 2

24

18

34

35

 + Interest expense 3

41

84

81

166

 - Non-operating pension/OPEB benefit (costs) credits 1

(1)

—

(1)

2

 - Foreign exchange gains (losses), net 1

4

(14)

14

(17)

+ Future Reimbursable Indirect Costs

—

25

8

50

+ Corporate DDOB Remediation Costs

6

2

10

5

- Significant items charge

(8)

(72)

(54)

(81)

Operating EBITDA (non-GAAP)

$         448

$         423

$         862

$         783

1.

Included in "Sundry income (expense) - net".

2.

The three and six months ended June 30, 2026 and 2025 excludes accrued interest income earned on employee retention credits. Refer to details of significant items on page 14.

3.

The six months ended June 30, 2025 excludes interest rate swap basis amortization. Refer to details of significant items on page 14.

Reconciliation of "Cash provided by operating activities - continuing
operations" to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free
Cash Flow1 and calculation of "Adjusted Free Cash Flow Conversion"
and "Transaction-Adjusted Free Cash Flow Conversion"

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Cash provided by operating activities (GAAP) 2 - continuing operations

$       400

$        74

$       632

$       151

Capital expenditures

(76)

(50)

(178)

(172)

Adjusted free cash flow (non-GAAP)

$       324

$        24

$       454

$       (21)

Separation-related transaction cost and other payments3

2

83

19

136

Transaction-adjusted free cash flow (non-GAAP)

$       326

$       107

$       473

$       115

Adjusted earnings (non-GAAP) 4

$       257

$       177

$       483

$       331

Adjusted free cash flow conversion (non-GAAP)

126 %

14 %

94 %

(6) %

Transaction-adjusted free cash flow conversion (non-GAAP)

127 %

60 %

98 %

35 %

1

Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 7-8 for additional information.

2

Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in "Cash provided by operating activities - continuing operations" for the six month periods noted.

3

Other payments for the three months ended June 30, 2026 includes $2 million related of separation-related capital expenditures. Other payments for the six months ended June 30, 2026 includes $5 million of separation-related capital expenditures, $6 million related to restructuring and short-term incentive program payments associated with former senior leadership, and $8 million for Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).

4

Refer to page 14 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP).

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Three Months Ended June 30, 2026

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     266

$     187

$    1.37

Less: Significant items

Acquisition, integration & separation costs

(7)

(5)

(0.04)

Acquisition, integration and separation costs

Restructuring and asset related benefits - net

3

—

—

Restructuring and asset related charges – net

Other benefits (credits), net 4

(4)

(3)

(0.02)

Sundry income (expense) - net; Selling, general and administrative expenses

Income tax items 5

—

(3)

(0.02)

Provision for income taxes on continuing operations

Total significant items

$      (8)

$     (11)

$   (0.08)

Less: Amortization of intangibles

(68)

(53)

(0.39)

Amortization of intangibles

Less: Non-op pension / OPEB benefit costs

(1)

(1)

(0.01)

Sundry income (expense) - net

Less: Corporate DDOB remediation costs

(6)

(5)

(0.03)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     349

$     257

$    1.88

Significant Items Impacting Results for the Three Months Ended June 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$      78

$      24

$    0.17

Less: Significant items

Acquisition, integration and separation costs

(55)

(46)

(0.32)

Acquisition, integration and separation costs

Restructuring and asset related benefits - net

—

1

—

Restructuring and asset related charges - net

Interest rate swap mark-to-market loss 6

(27)

(21)

(0.15)

Sundry income (expense) - net

Other benefits (credits), net 7

10

8

0.06

Sundry income (expense) - net

Income tax items 8

—

(18)

(0.13)

Provision for income taxes on continuing operations

Total significant items

$     (72)

$     (76)

$   (0.54)

Less: Amortization of intangibles

(74)

(58)

(0.42)

Amortization of intangibles

Less: Non-op pension / OPEB benefit credits

—

—

—

Sundry income (expense) - net

Less: Future reimbursable indirect costs

(25)

(19)

(0.14)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(2)

—

—

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     251

$     177

$    1.27

1.

Income (loss) from continuing operations before income taxes.

2.

Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

Earnings (loss) per common share from continuing operations - diluted.

4.

Includes benefits related to an adjustment of the Donatelle contingent earn-out liability ($8 million pre-tax benefit) and legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($7 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($8 million pre-tax cost).

5.

Reflects the net impact of a valuation allowance release in Europe and a deferred tax asset reversal in the U.S.

6.

The three months ended June 30, 2025 includes non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps.

7.

Reflects the accrued interest earned on employee retention credits ($3 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($12 million pre-tax benefit) and legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($5 million pre-tax cost).

8.

Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Six Months Ended June 30, 2026

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     447

$     334

$    2.43

Less: Significant items

Acquisition, integration & separation costs

(7)

(5)

(0.04)

Acquisition, integration and separation costs

Restructuring and asset related charges - net

(43)

(36)

(0.26)

Restructuring and asset related charges - net

Other benefits (credits), net 4

(4)

(3)

(0.02)

Sundry income (expense) - net; Selling, general and administrative expenses

Income tax items 5

—

15

0.11

Provision for income taxes on continuing operations

Total significant items

$     (54)

$     (29)

$   (0.21)

Less: Amortization of intangibles

(136)

(105)

(0.77)

Amortization of intangibles

Less: Non-op pension / OPEB benefit costs

(1)

(1)

(0.01)

Sundry income (expense) - net

Less: Future reimbursable indirect costs

(8)

(6)

(0.04)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(10)

(8)

(0.06)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     656

$     483

$    3.52

Significant Items Impacting Results for the Six Months Ended June 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     175

$     102

$    0.73

Less: Significant items

Acquisition, integration and separation costs

(105)

(89)

(0.63)

Acquisition, integration and separation costs

Restructuring and asset related charges - net

(39)

(32)

(0.23)

Restructuring and asset related charges - net

Interest rate swap mark-to-market loss 6

50

39

0.28

Sundry income (expense) - net; Interest expense

Other benefits (credits), net 7

13

11

0.08

Sundry income (expense) - net

Income tax items 8

—

(2)

(0.02)

Provision for income taxes on continuing operations

Total significant items

$     (81)

$     (73)

$   (0.52)

Less: Amortization of intangibles

(149)

(117)

(0.84)

Amortization of intangibles

Less: Non-op pension / OPEB benefit credits

2

2

0.01

Sundry income (expense) - net

Less: Future reimbursable indirect costs

(50)

(39)

(0.28)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(5)

(2)

(0.01)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     458

$     331

$    2.37

1.

Income (loss) from continuing operations before income taxes.

2.

Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

Earnings (loss) per common share from continuing operations - diluted.

4.

Reflects the accrued interest earned on employee retention credits ($3 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($14 million pre-tax benefit), legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($10 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($11 million pre-tax cost).

5.

Reflects the 2026 income tax benefit primarily the result of a discrete tax benefit relating to a change in tax classification of a non-U.S. legal entity ($20 million pre-tax benefit).

6.

The six months ended June 30, 2025 includes non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps. The six months ended June 30, 2025 also includes basis amortization on the 2022 Swaps ($1 million pre-tax, reflected in "Interest expense" within the Consolidated Statements of Operations).

7.

Reflects the accrued interest earned on employee retention credits ($6 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($12 million pre-tax benefit), legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($5 million pre-tax cost).

8.

Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.

SOURCE DuPont

Key Takeaways DOW is pursuing cost cuts and high-return growth projects amid ongoing market headwinds.DD is executing an innovation-led strategy and sharpening its portfolio through acquisitions and divestitures.Both companies face weak demand and higher costs, but differ in valuation, growth outlook and strategy. Dow Inc. (DOW - Free Report) and DuPont de Nemours, Inc. (DD - Free Report) are prominent U.S.-based chemical manufacturers, producing a wide range of chemicals and materials for various industries. They share a deep-rooted history in the American chemical industry, including a high-profile merger in 2017 and subsequent separation into distinct publicly traded companies in 2019.

Currently, both operate as restructured entities with diversified portfolios serving a vast array of end markets, including packaging, electronics, construction, automotive and agriculture. This comparison is particularly relevant for assessing which of these chemical industry leaders presents a more compelling investment opportunity in the current challenging market environment, as the industry remains mired in demand headwinds in certain markets and disruptions stemming from the Middle East conflict.

Let’s dive deep and closely compare the fundamentals of these two major chemical makers to determine which is the better investment now.

The Case for DowDOW benefits from its differentiated portfolio and advantaged feedstock positions in the Americas. It remains focused on investing in attractive areas. Its broad portfolio, significant low-cost feedstock positions, global footprint and market reach place it in an advantageous position against competitors. While Dow faces headwinds from heightened macroeconomic and geopolitical uncertainties, it remains focused on growth actions in attractive end markets and executing high-return incremental growth projects in cost-advantaged regions.

DOW has entered into a landmark agreement with Xylem to develop and operate advanced water systems at the Fort Saskatchewan, Alberta, Canada, manufacturing complex. The initiative further expands collaboration between these companies, supporting the advancement of DOW's Path2Zero initiative. The company also announced a series of targeted investments totaling approximately $100 million through 2027 to strengthen its global specialty silicones manufacturing and innovation. The initiative aims to support rising demand in fast-growing sectors such as mobility, electronics, and healthcare while enhancing supply chain resilience globally.

Dow is taking action to cut costs by $1 billion to drive margins. It expects to achieve the majority of the cost savings through reductions in direct and labor costs. Dow realized more than $400 million of benefits from these actions in 2025, with the remaining benefits expected by 2026.

DOW has launched the “Transform to Outperform” initiative to improve productivity, reduce complexity, streamline its end-to-end processes and enable improved returns. The plan targets at least $2 billion near-term operating EBITDA improvement, with two-thirds of the benefits expected to be realized from productivity improvements. The company expects EBITDA benefits of roughly $500 million from this program in 2026. It expects to deliver roughly $1.1 billion in benefits from self-help actions this year.

DOW has a strong balance sheet and generates substantial cash flows, which enable it to finance its growth investments in higher-value businesses and regions, and drive shareholder value. It ended the first quarter with solid liquidity of around $14 billion, including cash and cash equivalents of roughly $4.1 billion. It generated solid cash flow from operating activities of roughly $1.1 billion in the first quarter.

DOW returned $1.5 billion to its shareholders through dividends in 2025. Dow has a policy of returning roughly 45% of its operating net income through dividends. It paid $252 million in dividends in the first quarter. It has no substantial long-term debt maturities until 2029. DOW offers a healthy dividend yield of 4.7% at the current stock price.

Despite these positives, DOW is exposed to headwinds from a tepid demand environment. Lower consumer spending amid inflationary pressures is affecting demand in Europe. Construction and manufacturing activities remain soft in the region. Demand in Asia has been affected by a weaker demand recovery in China. The property sector in China remains sluggish, with declining new home prices.

Inflationary pressures are impacting consumer durables and building and construction demand. Demand in infrastructure, including residential construction, also remains weak. Dow is also seeing softness in automotive in Europe due to weak demand. Higher costs are also expected to impact the U.S. automotive market in 2026. Weak conditions across these markets are likely to impact volumes in second-quarter 2026.

The company faces headwinds from higher feedstock costs in Asia and Europe. The Middle East conflict and the blockade of the Strait of Hormuz have led to significant supply disruptions and feedstock cost pressure in these regions. Elevated feedstock and energy costs are likely to impact margins in the second quarter.

The Case for DuPontDuPont remains focused on driving growth through innovation and new product development. Its innovation-driven investment is focused on several high-growth areas. DD remains committed to driving returns from its R&D investment.

The acquisition of Spectrum Plastics Group, a leading manufacturer of specialty medical devices and components, strengthened DuPont’s position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market. The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments. The acquisition introduces complementary advanced technologies and capabilities, such as medical device injection molding, liquid silicone rubber processing, precision machining, device assembly and tool building.

DuPont also completed the divestiture of its Aramids business to Arclin for $1.8 billion in April 2026, allowing it to sharpen its focus on innovation-driven, higher-return businesses. The divestiture is expected to improve DuPont’s margin profile and reduce earnings volatility tied to cyclical end markets, while also strengthening its balance sheet and providing additional flexibility for capital allocation.

DuPont is also benefiting from cost synergy savings and productivity improvement actions. These actions contributed to a 100-basis-point year-over-year growth in operating margins in 2025. The additional benefits of its structural cost actions are expected to be realized in 2026. The company also continues to implement strategic price increases in the wake of raw material and energy cost inflation. Its cost and productivity actions, along with pricing measures, are expected to contribute to its margins this year. DuPont’s corporate cost reductions are expected to deliver margin expansion for this year, with the company expecting a 60-80 basis-point operating margin expansion.

The company remains focused on driving cash flow and returning value to its shareholders. It looks to boost cash flow through working capital productivity and earnings growth. Prudent working capital management is expected to allow it to achieve its projected transaction-adjusted free cash flow conversion of more than 90% in 2026. DuPont also remains committed to effective capital allocation.

DD’s board approved a new share repurchase authorization of up to $2 billion, with the company executing a $500 million accelerated share repurchase (ASR) transaction in the fourth quarter of 2025. It has announced a $275 million ASR under this program. DuPont offers a dividend yield of 1.8% at the current stock price. Its payout ratio is 25%.

On the flip side, DD is facing headwinds in the construction markets, which are impacting sales in its industrial business. In North America, uncertainties surrounding the U.S. housing market are weighing on construction. Elevated borrowing costs and inflation have taken a bite out of the residential construction industry. The weakness in construction and automotive markets is hurting sales in the diversified industrials business. The softness in the automotive market is due to weak automotive build rates across the United States and Europe.

DuPont is also exposed to challenges from cost inflation and logistics disruptions due to the Middle East conflict. The company faces challenges from higher raw material costs resulting from the conflict. While the company is taking pricing actions to offset the incremental costs, the impacts of cost inflation are expected to reflect on its margins in 2026. DuPont sees incremental costs of around $90 million in 2026, with maximum impact expected in the second half. Higher input costs are expected to weigh on margins in the second quarter.

Price Performance and Valuation of DOW & DDThe DOW stock is up 25.3% year to date, while DD has gained 11.3% compared with the Zacks Chemicals Diversified industry’s increase of 17.2%.

Image Source: Zacks Investment Research

DOW is currently trading at a forward price-to-sales ratio of 0.48, below the industry’s 0.88. 

Image Source: Zacks Investment Research

DD is currently trading at a forward price-to-sales ratio of 2.48, well above DOW and the industry.

Image Source: Zacks Investment Research

How the Zacks Consensus Estimate Compares for DOW & DDThe Zacks Consensus Estimate for Dow’s 2026 sales implies a year-over-year increase of 10.8%. The same for EPS suggests a 395.7% year-over-year rise. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

The consensus estimate for DuPont’s 2026 sales and EPS implies a year-over-year decline of 35.3% and an increase of 41.9%, respectively. The EPS estimates for 2026 have been trending southward over the past 60 days.

Image Source: Zacks Investment Research

DOW or DD: Which Stock Holds the Edge?Both DOW and DD currently carry a Zacks Rank #3 (Hold), so picking one stock is not easy. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

DOW benefits from its cost and productivity actions and investment in high-return projects. DuPont gains on its innovation-led strategy, healthcare expansion, disciplined capital allocation and healthy margin improvement backed by cost synergies. Both are exposed to weak demand in a challenging environment as well as cost headwinds. DOW appears to have an edge over DD due to its more attractive valuation. In addition, DOW's higher earnings growth projections suggest that it may offer better investment prospects in the current market environment.

Tailored direct lithium extraction solutions combine advanced sorbents, membranes, ion exchange resins, and technical expertise to enable high-performance lithium recovery across diverse brine compositions

, /PRNewswire/ -- DuPont (NYSE: DD) today announced it has launched an end-to-end Direct Lithium Extraction (DLE) portfolio comprising more than 20 products across multiple technologies, designed to improve lithium recovery and provide tailored solutions for diverse brine resources, supporting scalable lithium production amid accelerating global demand. As an alternative to traditional lithium processing approaches such as hard rock mining or evaporation, DLE is well positioned to support growing lithium demand through advanced separation technologies designed to extract lithium effectively and efficiently from brine.

The new DLE portfolio spans lithium-selective sorbents, nanofiltration and reverse osmosis membranes, and ion exchange resins across the entire lithium brine treatment process, from extraction and purification to final concentration. This integrated flowsheet design enables customers to implement end-to-end solutions or select individual technologies tailored to their specific process requirements and brine compositions.

A key differentiator of DuPont's new portfolio is its breadth and flexibility, which allows DuPont to design customized solutions across a wide range of lithium extraction applications. For example, the portfolio includes specialized lithium-selective DuPont™ AmberSorb™ adsorbent technologies for both high- and low-temperature brine streams to meet the needs for efficient lithium recovery from diverse global resources. In addition, DuPont provides different grades of FilmTec™ LiNE nanofiltration and reverse osmosis elements, offering unique separation characteristics and incorporation of low salt rejection reverse osmosis (LSRRO) technology to achieve ultra-high lithium concentration.

These capabilities are enhanced by advanced DuPont™ IntegraTec™ and Inge™ ultrafiltration modules, FilmTec™ nanofiltration and reverse osmosis membranes, and DuPont™ AmberLite™ ion exchange resins, which improve lithium yield, purity, and concentration throughout the process. By bringing these technologies together into a single, cohesive platform, DuPont enables customers to optimize performance and recovery across the full direct lithium extraction flowsheet.

"DLE processes are highly sensitive to the lithium brine composition, temperature, and competing ions. By integrating the lithium-selective sorbents, membranes, and ion exchange technologies into a single process design framework, we can optimize the full flowsheet rather than treating them in isolation," said Dr. Martin Deetz, Senior R&D Laureate for DuPont Water Solutions. "Our customers are trying to move from the lab to reliable lithium production as quickly as possible. By combining these technologies with advanced modeling, testing, and piloting support, we can help accelerate the design of tailored, end-to-end lithium extraction flowsheets for their specific brine resources and goals."

DuPont further supports customers through its global research and development network, offering advanced laboratory testing and process modeling. These services allow lithium producers to validate performance using real brine samples and accelerate process development. This approach positions DuPont as a technical collaborator, helping customers move from initial evaluation to implementation with greater speed, confidence, and process reliability. As demand for lithium surges to power electric vehicles and energy storage systems, the industry is increasingly adopting DLE as a more coordinated and efficient approach to unlocking new lithium resources.

DuPont's technical experts hosted an educational webinar on June 18, 2026 to help customers understand how tailored DLE technologies can increase lithium yield and purity while addressing the unique characteristics of their brine resources. The session highlighted how customers can leverage DuPont's testing, modeling, and piloting support to evaluate and implement customized solutions. Watch on-demand here: https://www.dupont.com/water/contact-us.html?dfp=water-webinar-direct-lithium-extraction&src=ws_global_newsletter_dlewebinar_website_pressrelease_2026-07-14 

Learn more about DuPont's Direct Lithium Extraction portfolio at https://www.dupont.com/water/applications/direct-lithium-extraction-solutions.html.

About DuPont

DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

SOURCE DuPont

Key Takeaways DuPont's WAVE PRO combines ultrafiltration, ion exchange, reverse osmosis and nanofiltration.The platform cuts data-entry errors and improves cost projections by linking process interdependencies.Advanced configurations support recycle streams and closed-loop conditions for complex water projects. DuPont de Nemours, Inc. (DD - Free Report) has introduced a major progress in its Water Application Value Engine (WAVE PRO), an advanced online water treatment modeling platform that now integrates ultrafiltration, ion exchange resins, reverse osmosis and nanofiltration into a single comprehensive tool.

The enhanced platform supports applications ranging from drinking water, industrial utility water, to wastewater and seawater desalination, enabling a more accurate, data-driven system that optimizes membrane and energy use, extends asset life and helps reduce the environmental footprint of water treatment.

By minimizing the need for separate simulations, WAVE PRO reduces manual data-entry errors while capturing the interdependencies between technologies, resulting in a more realistic and cost-effective projection system. The upgraded platform also offers more flexibility for complex projects by supporting advanced multi-process configurations, including recycle streams and closed-loop conditions.

WAVE PRO integrates DuPont's portfolio of water technologies, including IntegraTec and Inge ultrafiltration modules, AmberLite ion exchange resins, and FilmTec reverse osmosis and nanofiltration elements, within a single integrated digital ecosystem, helping municipalities and industrial water treatment while supporting global sustainability goals.

DD’s shares have slumped 40.4% over the past year compared with the industry’s 5.1% decline.

Image Source: Zacks Investment Research

DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold). 

Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .

While ALB sports a Zacks Rank #1 (Strong Buy) at present, CRS and ASM carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.98 per share, indicating a 1,743.04% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed one, with an average surprise of 74.5%. ALB’s shares have jumped 81% over the past year.

The Zacks Consensus Estimate for CRS’ 2026 earnings is pegged at $10.56 per share, indicating a rise of 41.18% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.95%.

The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 34 cents per share, indicating a 17.24% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%. ASM’s shares have gained 45.8% over the past year.